Industry insights: The evolution of cell therapies with Katy Newton

How has cell and gene therapy evolved from scientific ambition to clinical reality? In this video, Kella Kapnisi, Head of Cell and Gene Therapy at Team Consulting, speaks with Katy Newton, Chief Scientific Officer at MFX, about the evolution of cell and gene therapies, the challenges of commercialisation and the opportunities that could shape the future of advanced therapeutics. With her background of developing T-cell therapies and consulting in the cell and gene therapy space, Katy reflects on the industry's journey from an emerging scientific concept to a therapeutic modality capable of delivering meaningful patient outcomes. The discussion explores the role of process analytics, regulatory development and cross-disciplinary collaboration in overcoming the challenges that remain. The conversation explores: 00:26 Chapter 1 – Katy's journey into cell and gene therapy and what inspired his career 02:40 Chapter 2 – How the cell and gene therapy industry has evolved over the past two decades 05:34 Chapter 3 – How process analytics can help address commercial and manufacturing challenges 13:31 Chapter 4 – The transition from scientific possibility to real-world clinical impact 24:07 Chapter 5 – Why collaboration, cross-training and diverse expertise will shape the future of the industry Katy discusses how the field has matured from an emerging area of research into an established therapeutic approach delivering tangible benefits for patients. The conversation highlights the importance of balancing scientific innovation with quality, safety and commercial viability, while ensuring therapies remain accessible to the people who need them most. Katy shares why developing a stronger pipeline of interdisciplinary talent could be just as important as developing the next generation of therapies. About Team Consulting With 40 years of medical device and healthcare innovation experience, Team Consulting's in-house team of applied scientists, engineers and designers supports clients in developing breakthrough healthcare technologies, from advanced drug delivery systems and digital health solutions to next-generation cell and gene therapies. Visit Team Consulting's website to learn more: https://www.team-consulting.com/